TGFβ1 regulates the inflammatory response during chronic neurodegeneration

被引:78
作者
Boche, Delphine [1 ]
Cunningham, Colm
Docagne, Fabian
Scotta, Helen
Perry, V. Hugh
机构
[1] Univ Southampton, Sch Biol Sci, CNS Inflammat Grp, Southampton Neurosci Grp, Southampton SO16 7PX, Hants, England
[2] CSIC, Inst Ramon & Cajal, Lab Neuroimmunol, Madrid, Spain
基金
英国惠康基金;
关键词
priori; microglia; activation; TGF beta 1; decorin; neurodegeneration; iNOS;
D O I
10.1016/j.nbd.2006.01.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The ME7 model of murine prion disease shows an atypical inflammatory response characterized by morphologically activated microglia and an anti-inflammatory cytokine profile with a marked expression of TGF beta 1. The investigation of the role of TGF beta 1 during a time course disease shows that its expression is correlated with (i) the onset of behavioral abnormalities, (ii) increased activated microglia, (iii) thickening of the basement membrane, and (iv) is associated with increased PrPsc deposition. Increasing TGF beta 1 using an adenoviral vector has no significant impact on prion-associated behavioral impairments or on neuropathology. In contrast, inhibition of TGF beta 1 activity using an adenovirus expressing decorin induces severe cerebral inflammation, expression of inducible nitric oxide synthase and acute neuronal death in prion-diseased animals only. These data suggest that TGF beta 1 plays a critical role in the downregulation of microglial responses minimizing brain inflammation and thus avoiding exacerbation of brain damage. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:638 / 650
页数:13
相关论文
共 68 条
[31]  
Gupta A, 2003, INT J CLIN PRACT, V57, P36
[32]   INTERACTION OF THE SMALL INTERSTITIAL PROTEOGLYCANS BIGLYCAN, DECORIN AND FIBROMODULIN WITH TRANSFORMING GROWTH-FACTOR-BETA [J].
HILDEBRAND, A ;
ROMARIS, M ;
RASMUSSEN, LM ;
HEINEGARD, D ;
TWARDZIK, DR ;
BORDER, WA ;
RUOSLAHTI, E .
BIOCHEMICAL JOURNAL, 1994, 302 :527-534
[33]   Cognitive deficits induced by global cerebral ischaemia: Prospects for transplant therapy [J].
Hodges, H ;
Nelson, A ;
Virley, D ;
Kershaw, TR ;
Sinden, JD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 56 (04) :763-780
[34]   Systemic infection, interleukin 1β, and cognitive decline in Alzheimer's disease [J].
Holmes, C ;
El-Okl, M ;
Williams, AL ;
Cunningham, C ;
Wilcockson, D ;
Perry, VH .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (06) :788-789
[35]   Cytokine-induced sickness behaviour: mechanisms and implications [J].
Konsman, JP ;
Parnet, P ;
Dantzer, R .
TRENDS IN NEUROSCIENCES, 2002, 25 (03) :154-159
[36]   Microglia: A sensor for pathological events in the CNS [J].
Kreutzberg, GW .
TRENDS IN NEUROSCIENCES, 1996, 19 (08) :312-318
[37]  
Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363
[38]   Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention [J].
Liu, B ;
Hong, JS .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (01) :1-7
[39]  
MASSAGUE J, 1992, CANCER SURV, V12, P81
[40]   Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum [J].
Milatovic, D ;
Zaja-Milatovic, S ;
Montine, KS ;
Horner, PJ ;
Montine, TJ .
JOURNAL OF NEUROCHEMISTRY, 2003, 87 (06) :1518-1526